- Home
- BKD vs CLDX Comparison
BKD vs CLDX Comparison
Compare BKD & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKD
- CLDX
- Stock Information
- Founded
- BKD 2005
- CLDX N/A
- Country
- BKD United States
- CLDX United States
- Employees
- BKD N/A
- CLDX N/A
- Industry
- BKD Hospital/Nursing Management
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BKD Health Care
- CLDX Health Care
- Exchange
- BKD Nasdaq
- CLDX Nasdaq
- Market Cap
- BKD 1.5B
- CLDX 1.3B
- IPO Year
- BKD 2005
- CLDX 2008
- Fundamental
- Price
- BKD $6.38
- CLDX $19.97
- Analyst Decision
- BKD Buy
- CLDX Buy
- Analyst Count
- BKD 5
- CLDX 9
- Target Price
- BKD $7.70
- CLDX $50.00
- AVG Volume (30 Days)
- BKD 2.7M
- CLDX 918.0K
- Earning Date
- BKD 05-06-2025
- CLDX 05-08-2025
- Dividend Yield
- BKD N/A
- CLDX N/A
- EPS Growth
- BKD N/A
- CLDX N/A
- EPS
- BKD N/A
- CLDX N/A
- Revenue
- BKD $3,015,786,000.00
- CLDX $7,559,000.00
- Revenue This Year
- BKD $8.43
- CLDX N/A
- Revenue Next Year
- BKD N/A
- CLDX N/A
- P/E Ratio
- BKD N/A
- CLDX N/A
- Revenue Growth
- BKD 4.14
- CLDX 24.49
- 52 Week Low
- BKD $4.45
- CLDX $14.40
- 52 Week High
- BKD $8.12
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- BKD 45.12
- CLDX 51.66
- Support Level
- BKD $6.31
- CLDX $18.55
- Resistance Level
- BKD $6.60
- CLDX $20.67
- Average True Range (ATR)
- BKD 0.19
- CLDX 1.18
- MACD
- BKD -0.06
- CLDX -0.06
- Stochastic Oscillator
- BKD 15.83
- CLDX 56.39
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.